ANVERSA PIERO has a total of 21 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are NAT CENTER OF NEUROLOGY & PSYCHIATRY, TISSUEGENE INC and HADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Enzymes | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Anversa Piero | 21 |
#2 | Leri Annarosa | 16 |
#3 | Kajstura Jan | 15 |
#4 | Goihberg Polina | 2 |
Publication | Filing date | Title |
---|---|---|
WO2011057249A2 | Treatment of heart disease | |
WO2011057251A2 | Treatment of heart disease | |
US2011123500A1 | Methods of isolating non-senescent cardiac stem cells and uses thereof | |
WO2009073616A2 | Compositions comprising vascular and myocyte progenitor cells and methods of their use | |
US2009157046A1 | Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof |